Australia markets open in 1 hour 29 minutes

PYC Therapeutics Limited (PYC.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0720-0.0010 (-1.37%)
At close: 01:41PM AEST

PYC Therapeutics Limited

Harry Perkins Institute
6 Verdun Street
Nedlands, WA 6009
61 8 6151 0992

Sector(s):Β Healthcare
Industry:Β Biotechnology
Full-time employees:Β 

Key executives

NameTitlePayExercisedYear born
Dr. Rohan Hockings G.D.L.P, J.D., MBBS, MBBS (Hons.)CEO & Exec. Director432.46kN/A1983
Mr. Kevin Ronald Hart B.Com, B.Comm (Hons), C.A., F.C.A., FCACompany Sec. & CFON/AN/A1962
Prof. Sue FletcherChief Scientific OfficerN/AN/AN/A
Mr. Kaggen Ausma L.L.B.Chief Bus. OfficerN/AN/AN/A
Dr. May Orfali M.B.A., M.D.Chief Medical Officer of US OperationsN/AN/A1968
Dr. Glenn NoronhaChief Devel. OfficerN/AN/A1965
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


PYC Therapeutics Limited, a development-stage biotechnology company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia. The company's preclinical development programs include VP-001, drug program for retinitis pigmentosa type 11; and VP-002, a drug program for the treatment of autosomal dominant optic atrophy. It also focuses on the development of programs for retinal and central nervous system diseases. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.

Corporate governance

PYC Therapeutics Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.